Undisclosed RPT Programs
Hard-to-treat Cancers
PreclinicalActive
Key Facts
About Archeus Technologies
Archeus Technologies is a preclinical radiopharmaceutical company with a leadership team combining deep expertise in medical physics, clinical oncology, radiochemistry, and business development. The company is developing a pipeline of small-molecule RPTs and companion diagnostics with curative intent for difficult cancers. While still in preclinical development and pre-revenue, its strong academic ties and experienced leadership position it to advance its targeted agents into human clinical trials.
View full company profileTherapeutic Areas
Other Hard-to-treat Cancers Drugs
| Drug | Company | Phase |
|---|---|---|
| ADC Joint Venture (with Alloy Therapeutics) | Tahoe Therapeutics | Pre-clinical |